326 related articles for article (PubMed ID: 17660072)
1. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
[TBL] [Abstract][Full Text] [Related]
2. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
3. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human thrombin: in surgical hemostasis.
Croxtall JD; Scott LJ
BioDrugs; 2009; 23(5):333-8. PubMed ID: 19754221
[TBL] [Abstract][Full Text] [Related]
5. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery.
Doria C; Fischer CP; Wood CG; Li PM; Marra S; Hart J
Curr Med Res Opin; 2008 Mar; 24(3):785-94. PubMed ID: 18241525
[TBL] [Abstract][Full Text] [Related]
6. Topical use of recombinant human thrombin for operative hemostasis.
Anderson CD; Bowman LJ; Chapman WC
Expert Opin Biol Ther; 2009 Jan; 9(1):133-7. PubMed ID: 19063699
[TBL] [Abstract][Full Text] [Related]
7. Topical recombinant human thrombin in surgical hemostasis.
Bowman LJ; Anderson CD; Chapman WC
Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
[TBL] [Abstract][Full Text] [Related]
8. Preclinical safety of recombinant human thrombin.
Heffernan JK; Ponce RA; Zuckerman LA; Volpone JP; Visich J; Giste EE; Jenkins N; Boster D; Pederson S; Knitter G; Palmer T; Wills M; Early RJ; Rogge MC
Regul Toxicol Pharmacol; 2007 Feb; 47(1):48-58. PubMed ID: 16971028
[TBL] [Abstract][Full Text] [Related]
9. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
10. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.
Bochicchio GV; Gupta N; Porte RJ; Renkens KL; Pattyn P; Topal B; Troisi RI; Muir W; Chetter I; Gillen DL; Zuckerman LA; Frohna PA
J Am Coll Surg; 2015 Jan; 220(1):70-81. PubMed ID: 25458801
[TBL] [Abstract][Full Text] [Related]
11. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
[TBL] [Abstract][Full Text] [Related]
13. Prospective, Randomized, Phase II, Non-Inferiority Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgery.
Minkowitz H; Navarro-Puerto J; Lakshman S; Singla S; Cousar C; Kim R; Villavicencio A; Kirksey L; Ayguasanosa J;
J Am Coll Surg; 2019 Nov; 229(5):497-507.e1. PubMed ID: 31376435
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis.
Singla NK; Gasparis AP; Ballard JL; Baron JM; Butine MD; Pribble JP; Alexander WA;
J Am Coll Surg; 2011 Dec; 213(6):722-7. PubMed ID: 21958507
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials.
Singla NK; Foster KN; Alexander WA; Pribble JP
Pharmacotherapy; 2012 Nov; 32(11):998-1005. PubMed ID: 23108631
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.
Bishop PD; Lewis KB; Schultz J; Walker KM
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():86-97. PubMed ID: 16673270
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of a dry-powder, fibrin sealant in vascular procedures.
Gupta N; Chetter I; Hayes P; O-Yurvati AH; Moneta GL; Shenoy S; Pribble JP; Zuckerman LA
J Vasc Surg; 2015 Nov; 62(5):1288-95. PubMed ID: 26254451
[TBL] [Abstract][Full Text] [Related]
19. Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study.
Björses K; Holst J
Eur J Vasc Endovasc Surg; 2007 Mar; 33(3):363-70. PubMed ID: 17137801
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts.
Saha SP; Muluk S; Schenk W; Dennis JW; Ploder B; Grigorian A; Presch I; Goppelt A
J Vasc Surg; 2012 Jul; 56(1):134-41. PubMed ID: 22633423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
